Envestnet Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Envestnet Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-778	Closed	-$77K	–	3129
2018 Q2	$77K	Hold	778	–	–	﹤0.01%	2059
2018 Q1	$63K	Buy	778 +74	+11%	+$5.98K	﹤0.01%	2081
2017 Q4	$56K	Buy	704 +57	+9%	+$4.74K	﹤0.01%	2294
2017 Q3	$60K	Buy	+647	New	+$62.2K	﹤0.01%	2234
2017 Q2	–	Sell	-1,091	Closed	-$110K	–	3202
2017 Q1	$110K	Sell	1,091 -16,798	-94%	-$1.8M	﹤0.01%	2146
2016 Q4	$1.92M	Buy	17,889 +102	+0.6%	+$11.9K	0.01%	940
2016 Q3	$2.21M	Sell	17,787 -716	-4%	-$84.5K	0.01%	911
2016 Q2	$1.97M	Buy	18,503 +258	+1%	+$30K	0.01%	1046
2016 Q1	$2.09M	Buy	18,245 +16,458	+921%	+$1.93M	0.01%	966
2015 Q4	$255K	Sell	1,787 -229	-11%	-$26.4K	﹤0.01%	1909
2015 Q3	$181K	Buy	+2,016	New	+$213K	﹤0.01%	2054

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Envestnet Asset Management's CBPO Position: Q3 2018 in Review

Envestnet Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2018, closing a stake of 778 shares — an estimated $77K sold.

Envestnet Asset Management first reported a position in CBPO in Q3 2015 and held it in 11 quarters. The position peaked at $2.21M in Q3 2016. 82 funds tracked by Wall St. Rank hold CBPO as of Q3 2018.

Envestnet Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2018 after selling out during the quarter.
Envestnet Asset Management sold 778 China Biologic Products Holdings, Inc. shares in Q3 2018, an estimated $77K.
Envestnet Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 11 quarters.
Envestnet Asset Management's China Biologic Products Holdings, Inc. position peaked at $2.21M in Q3 2016.
82 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2018.

Based on Envestnet Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.